Director Barthelemy Nicolas bought 1,200 shares (1.2K) of RGEN at $125.45 amid cluster buying; stock down -39.7% from 52-week high of $208.42.
Director Barthelemy Nicolas purchased 1,200 shares at $125.45 on 2024-06-14, increasing his holdings by 34.6% to 4,668 shares post-transaction. This buy is part of a cluster pattern with 2 other insiders purchasing within the past 14 days. The transaction occurs as RGEN trades at $125.62, down -39.7% from its 52-week high of $208.42 and -28.6% over the past 30 days. The company's fundamentals show deteriorating performance: annual revenue growth stands at -20.3%, net income of only $2.1M on revenue of $151.3M reflects significant profitability pressure, and the P/E of 465.26 indicates the market is pricing in recovery expectations. The coordinated insider buying in a context of depressed valuation and shared operational headwinds—rather than transaction-specific timing—is the signal worth monitoring.